ArticleClinical and molecular hepatology2026

Aspirin and hepatocellular carcinoma risk in metabolic dysfunction-associated steatotic liver disease: nationwide cohort study with genetic risk analysis.

Juhee Ahn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.